Novavax begins Phase 1 Clinical Trial of A(H7N9) Influenza vaccine

Enrolment for the Phase 1 clinical trial of Novavax's vaccine candidate for the prevention of disease due to A(H7N9) avian influenza viruses has begun, the biopharmaceutical company announced yesterday.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news